Baxter price target raised to $27 from $25 at Barclays

Barclays raised the firm’s price target on Baxter (BAX) to $27 from $25 and keeps an Overweight rating on the shares. The comapny surprised investors expecting a guidance cut with a “respectable beat and reiterated outlook,” the analyst tells investors in a research note.